With Eucerin DERMOPURE CLINICAL PROBIOM8, Beiersdorf is introducing a new skin care approach for acne-prone skin.

Beiersdorf is doubling down on venture capital as a strategic lever to drive future growth through science-based innovation, launching the second generation of its corporate venture capital fund with a €100 million commitment.

Thiamidol is recommended 100% as the first-line dermocosmetic ingredient for facial hyperpigmentation and for maintenance therapy.

NIVEA serum featuring skin rejuvenation ingredient EPICELLINE®

Young people rank as the loneliest age group

Beiersdorf continues to invest in innovative strength

New innovation alliance shapes the future of skin science

Educational campaign to expand knowledge about wound healing

Largest academic research alliance in company history in the US

Beiersdorf receives approval of hero ingredient Thiamidol in China